Skip to main content
About
Case Studies
Testimonials
Board members
Investors
Management team
Contact us
Services
Offerings
Protein Science
X-ray crystallography
Assay Development
Biophysics
Biochemistry
Synthetic Chemistry
Virtual screening
Screening
Computational Chemistry
Medicinal Chemistry
Cell Biology
ADME and Bioanalytical Sciences
Analytical Sciences
Research Phases
Hit Identification
Hit to Lead
Lead Optimisation
Therapeutic Areas
Oncology
Immuno-Oncology
Cardiovascular
Respiratory
Anti-infectives
Inflammatory diseases
Target Classes
Kinases
GPCRs
Proteases
Methyltransferases
Ion Channels
Protein-Protein Interactions
Approaches
CDH (Target Gene Fragmentation)
PoLiPa (Membrane Protein Solubilisation)
LeadBuilder
FragmentBuilder
Fragment Based Drug Design (FBDD)
Structure Based Drug Design (SBDD)
Library
Brochures
Posters
Presentations
Publications
White Papers
News & Events
Careers
Search
Enquire
News & Events
Breadcrumb
Home
News & Events
News
APEIRON Biologics AG and Domainex Ltd announce the expansion of their partnership to progress targeted cancer immune therapy drug discovery
9 Nov '20
Press Release
‘Are we seeing long-term shifts in the Scientific Research Landscape?’ webinar presented by Domainex as part of the OBN Digital Event Series
19 Oct '20
Blog Post
How can Domainex enrich your medicines pipeline?
14 Sep '20
Blog Post
Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia.
14 Jul '20
Press Release
Domainex announces the appointment of Dr. Eddy Littler as non-executive Chairman
2 Jun '20
Press Release
Coronavirus/COVID-19 update
17 Mar '20
News Article
Events
Nov
26
31st Symposium on Medicinal chemistry in Eastern England
Dec
10
Genesis 2020
Feb
25
OBN Awards
Jun
17
BioForward
Jul
5
Kinase 2021
Tweets
Tweets by Domainex_UK
Start your next project with Domainex
Contact one of our experts today
